CYCURION INC C/WTS 13/02/2030 (TO PUR COM) | 10-K: FY2025 Revenue: USD 15.13 M
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025, the actual value is USD 15.13 M.
EPS: As of FY2025, the actual value is USD -13.39.
EBIT: As of FY2025, the actual value is USD -21.68 M.
Segment Revenue
- Advisory Consulting Revenue:
- 2025: $15,007,827
- 2024: $17,441,216
- Managed Security Service Practice (MSSP) Revenue:
- 2025: $112,725
- 2024: $318,079
- Software as a Service (SaaS) Revenue:
- 2025: $13,095
- 2024: $12,190
Operational Metrics (Consolidated)
- Net Revenues:
- 2025: $15,133,647
- 2024: $17,771,485
- YoY Change: Decreased $2.6 million or 14.8% in 2025 compared to 2024 due to delayed start dates of new federal, state, and local contracts and a focus on more profitable business.
- Cost of Revenues:
- 2025: $13,521,329
- 2024: $14,136,742
- YoY Change: Decreased in line with the decrease in revenues.
- Gross Profit:
- 2025: $1,612,318
- 2024: $3,634,743
- Gross Profit Percentage:
- 2025: 10.7%
- 2024: 20.5%
- Selling, General and Administrative (SG&A) Expenses:
- 2025: $9,258,199
- 2024: $1,208,630
- YoY Change: Increased in 2025 due to increased costs associated with being a publicly traded company and the addition of key individuals for growth strategy.
- Stock Compensation Expenses:
- 2025: $3,898,867
- 2024: $10,000
- YoY Change: Increased in 2025 due to new compensation agreements with executives.
- Business Combination Expenses:
- 2025: $11,870,114
- 2024: - $0
- YoY Change: Expenses in 2025 were a result of the business combination with Western.
- Total Operating Expenses:
- 2025: $25,027,180
- 2024: $1,218,630
- Operating (Loss)/Income:
- 2025: - $23,414,862
- 2024: $2,416,113
- Interest Income:
- 2025: $27,538
- 2024: $20,211
- Interest Expense:
- 2025: - $1,763,831
- 2024: - $1,209,502
- Gain on Debt Settlement, Net:
- 2025: $1,221,635
- 2024: - $0
- YoY Change: The gain in 2025 resulted from the conversion of debt to equity instruments at a lower fair market value.
- Net (Loss)/Income Attributable to Cycurion:
- 2025: - $23,665,708
- 2024: $1,229,601
Cash Flow (Consolidated)
- Net Cash Used in Operating Activities:
- 2025: - $12,086,357
- 2024: - $1,371,281
- YoY Change: Increased in 2025 primarily due to additional merger expenses and corporate-level costs for management team and brand building.
- Net Cash Provided by/(Used in) Investing Activities:
- 2025: $1,414,523 (provided)
- 2024: - $885,066 (used)
- YoY Change: Cash inflow in 2025 was due to the Trust Account for redemption and cash released from the Trust Account to the Company.
- Net Cash Provided by Financing Activities:
- 2025: $15,886,279
- 2024: $1,689,268
- Notable inflows in 2025 included $7.0 million from equity line of credit, $4.8 million from private placement, $3.7 million from warrant exercises, $2.4 million from convertible notes payable, and $0.5 million from notes payable, partially offset by $1.0 million used in common stock redemption.
Unique Metrics
- Committed Backlog:
- As of December 31, 2025: $80.0 million
- As of December 31, 2024: $16.0 million
Outlook / Guidance
Cycurion, Inc. anticipates approximately $1.35 million in combined revenue for 2026 from two new contract awards. Of this, $1.165 million is expected to be new annual recurring revenue. These awards include a multi-year engagement with a large healthcare government agency and an expanded relationship with the National Association of County and City Health Officials.
